

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of guanylate cyclase activity (GO:0031282) | 7.05301748 |
| 2 | cellular glucuronidation (GO:0052695) | 6.80108922 |
| 3 | maintenance of gastrointestinal epithelium (GO:0030277) | 6.56333295 |
| 4 | polyketide metabolic process (GO:0030638) | 6.54374549 |
| 5 | doxorubicin metabolic process (GO:0044598) | 6.54374549 |
| 6 | daunorubicin metabolic process (GO:0044597) | 6.54374549 |
| 7 | glucuronate metabolic process (GO:0019585) | 6.51575357 |
| 8 | uronic acid metabolic process (GO:0006063) | 6.51575357 |
| 9 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.26072874 |
| 10 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.83092919 |
| 11 | positive regulation of respiratory burst (GO:0060267) | 5.76488492 |
| 12 | angiotensin maturation (GO:0002003) | 5.69292885 |
| 13 | renal system process involved in regulation of blood volume (GO:0001977) | 5.63632473 |
| 14 | transcytosis (GO:0045056) | 5.56392921 |
| 15 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.20274186 |
| 16 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.17438814 |
| 17 | endocrine process (GO:0050886) | 5.17438814 |
| 18 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.17438814 |
| 19 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.14728074 |
| 20 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.14728074 |
| 21 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 5.11744433 |
| 22 | O-glycan processing (GO:0016266) | 4.98921836 |
| 23 | response to pheromone (GO:0019236) | 4.87953281 |
| 24 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.84237959 |
| 25 | intestinal epithelial cell development (GO:0060576) | 4.82759643 |
| 26 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.82081614 |
| 27 | epoxygenase P450 pathway (GO:0019373) | 4.67913177 |
| 28 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.63817158 |
| 29 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.62560223 |
| 30 | epithelial structure maintenance (GO:0010669) | 4.61360153 |
| 31 | * sulfate transmembrane transport (GO:1902358) | 4.60927885 |
| 32 | ethanol oxidation (GO:0006069) | 4.53948413 |
| 33 | glomerular filtration (GO:0003094) | 4.50383157 |
| 34 | regulation of systemic arterial blood pressure (GO:0003073) | 4.47542442 |
| 35 | NADH metabolic process (GO:0006734) | 4.46516514 |
| 36 | regulation of cGMP biosynthetic process (GO:0030826) | 4.25747448 |
| 37 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.20838891 |
| 38 | cGMP-mediated signaling (GO:0019934) | 4.18290611 |
| 39 | positive regulation of pseudopodium assembly (GO:0031274) | 4.12556101 |
| 40 | renal filtration (GO:0097205) | 4.11220643 |
| 41 | intestinal absorption (GO:0050892) | 4.08923987 |
| 42 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 4.00765470 |
| 43 | positive regulation of fatty acid oxidation (GO:0046321) | 4.00224987 |
| 44 | regulation of cholesterol homeostasis (GO:2000188) | 3.92946895 |
| 45 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.91683271 |
| 46 | diol metabolic process (GO:0034311) | 3.89038139 |
| 47 | regulation of cellular extravasation (GO:0002691) | 3.88722201 |
| 48 | flavonoid metabolic process (GO:0009812) | 3.88684701 |
| 49 | * sulfate transport (GO:0008272) | 3.87456434 |
| 50 | drug transmembrane transport (GO:0006855) | 3.86225119 |
| 51 | fucose catabolic process (GO:0019317) | 3.84696742 |
| 52 | L-fucose metabolic process (GO:0042354) | 3.84696742 |
| 53 | L-fucose catabolic process (GO:0042355) | 3.84696742 |
| 54 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.84482045 |
| 55 | sphingoid metabolic process (GO:0046519) | 3.83803027 |
| 56 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.82257356 |
| 57 | negative regulation of myotube differentiation (GO:0010832) | 3.75769406 |
| 58 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.73523212 |
| 59 | regulation of respiratory burst (GO:0060263) | 3.73424177 |
| 60 | regulation of pseudopodium assembly (GO:0031272) | 3.69126440 |
| 61 | drug metabolic process (GO:0017144) | 3.62360378 |
| 62 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.61871767 |
| 63 | sodium ion homeostasis (GO:0055078) | 3.61720509 |
| 64 | one-carbon metabolic process (GO:0006730) | 3.58217328 |
| 65 | labyrinthine layer development (GO:0060711) | 3.57865615 |
| 66 | cellular anion homeostasis (GO:0030002) | 3.56501013 |
| 67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.56367481 |
| 68 | ethanol metabolic process (GO:0006067) | 3.55334047 |
| 69 | sulfation (GO:0051923) | 3.50762994 |
| 70 | lipoprotein transport (GO:0042953) | 3.50144845 |
| 71 | drug transport (GO:0015893) | 3.49455952 |
| 72 | regulation of cGMP metabolic process (GO:0030823) | 3.49346070 |
| 73 | nucleotide transmembrane transport (GO:1901679) | 3.48691855 |
| 74 | sulfur amino acid catabolic process (GO:0000098) | 3.42127207 |
| 75 | positive regulation of lipid catabolic process (GO:0050996) | 3.40043674 |
| 76 | auditory receptor cell differentiation (GO:0042491) | 3.37618929 |
| 77 | interferon-gamma production (GO:0032609) | 3.36945197 |
| 78 | diacylglycerol metabolic process (GO:0046339) | 3.36456604 |
| 79 | cellular response to pH (GO:0071467) | 3.35539144 |
| 80 | presynaptic membrane assembly (GO:0097105) | 3.33744883 |
| 81 | protein O-linked glycosylation (GO:0006493) | 3.32495466 |
| 82 | hormone catabolic process (GO:0042447) | 3.32174780 |
| 83 | positive regulation of prostaglandin secretion (GO:0032308) | 3.30558741 |
| 84 | auditory receptor cell stereocilium organization (GO:0060088) | 3.28701477 |
| 85 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.28344354 |
| 86 | urea cycle (GO:0000050) | 3.27859413 |
| 87 | dendritic cell chemotaxis (GO:0002407) | 3.24892784 |
| 88 | antibacterial humoral response (GO:0019731) | 3.22617887 |
| 89 | kidney morphogenesis (GO:0060993) | 3.20745714 |
| 90 | fucose metabolic process (GO:0006004) | 3.20523481 |
| 91 | exogenous drug catabolic process (GO:0042738) | 3.20449915 |
| 92 | desmosome organization (GO:0002934) | 3.20140926 |
| 93 | protein heterotetramerization (GO:0051290) | 3.20094914 |
| 94 | regulation of vitamin metabolic process (GO:0030656) | 3.19779964 |
| 95 | glycerol metabolic process (GO:0006071) | 3.19233314 |
| 96 | drug catabolic process (GO:0042737) | 3.19209299 |
| 97 | receptor recycling (GO:0001881) | 3.18621309 |
| 98 | sphingomyelin metabolic process (GO:0006684) | 3.14409734 |
| 99 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.13851417 |
| 100 | lung secretory cell differentiation (GO:0061140) | 3.12990982 |
| 101 | regulation of interleukin-1 secretion (GO:0050704) | 3.12928826 |
| 102 | nucleotide-sugar metabolic process (GO:0009225) | 3.12617452 |
| 103 | digestive system process (GO:0022600) | 3.11641282 |
| 104 | vitamin transmembrane transport (GO:0035461) | 3.11222925 |
| 105 | phenylpropanoid metabolic process (GO:0009698) | 3.11129588 |
| 106 | antimicrobial humoral response (GO:0019730) | 3.10605156 |
| 107 | glycosphingolipid catabolic process (GO:0046479) | 3.10046244 |
| 108 | * sulfur compound transport (GO:0072348) | 3.09937144 |
| 109 | regulation of bile acid biosynthetic process (GO:0070857) | 3.09555802 |
| 110 | glycosylceramide metabolic process (GO:0006677) | 3.09516224 |
| 111 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.08793690 |
| 112 | hepatocyte apoptotic process (GO:0097284) | 3.08787523 |
| 113 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.05837359 |
| 114 | urea metabolic process (GO:0019627) | 3.05389527 |
| 115 | regulation of pigment cell differentiation (GO:0050932) | 3.04650728 |
| 116 | intermediate filament organization (GO:0045109) | 3.04130496 |
| 117 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.02902872 |
| 118 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.02657412 |
| 119 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.02336967 |
| 120 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.02336967 |
| 121 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.02336967 |
| 122 | cGMP biosynthetic process (GO:0006182) | 3.01159310 |
| 123 | sialylation (GO:0097503) | 3.01142271 |
| 124 | glycolipid catabolic process (GO:0019377) | 2.99932107 |
| 125 | digestion (GO:0007586) | 2.99928960 |
| 126 | vitamin A metabolic process (GO:0006776) | 2.98370079 |
| 127 | striated muscle atrophy (GO:0014891) | 2.98301962 |
| 128 | dendritic cell migration (GO:0036336) | 2.96898843 |
| 129 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.96729509 |
| 130 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.94681776 |
| 131 | regulation of chemokine secretion (GO:0090196) | 2.94193579 |
| 132 | glucocorticoid biosynthetic process (GO:0006704) | 2.93934790 |
| 133 | regulation of protein glycosylation (GO:0060049) | 2.93642581 |
| 134 | eosinophil chemotaxis (GO:0048245) | 2.91768552 |
| 135 | regulation of histone H3-K27 methylation (GO:0061085) | 2.89364061 |
| 136 | regulation of actin nucleation (GO:0051125) | 2.88042691 |
| 137 | detection of molecule of bacterial origin (GO:0032490) | 2.87202280 |
| 138 | regulation of keratinocyte proliferation (GO:0010837) | 2.86314334 |
| 139 | actin filament depolymerization (GO:0030042) | 2.84949372 |
| 140 | bile acid and bile salt transport (GO:0015721) | 2.83266697 |
| 141 | muscle atrophy (GO:0014889) | 2.83049196 |
| 142 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.82389231 |
| 143 | negative regulation of protein autophosphorylation (GO:0031953) | 2.79477275 |
| 144 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.79354673 |
| 145 | sphingosine metabolic process (GO:0006670) | 2.78253689 |
| 146 | phosphate ion homeostasis (GO:0055062) | 2.78046338 |
| 147 | trivalent inorganic anion homeostasis (GO:0072506) | 2.78046338 |
| 148 | oligosaccharide catabolic process (GO:0009313) | 2.77967341 |
| 149 | oligosaccharide biosynthetic process (GO:0009312) | 2.77345254 |
| 150 | thrombin receptor signaling pathway (GO:0070493) | 2.76726027 |
| 151 | positive regulation of icosanoid secretion (GO:0032305) | 2.73339176 |
| 152 | postsynaptic membrane organization (GO:0001941) | 2.73129789 |
| 153 | mature B cell differentiation (GO:0002335) | 2.72156863 |
| 154 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.71218390 |
| 155 | presynaptic membrane organization (GO:0097090) | 2.70582760 |
| 156 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.69982589 |
| 157 | neural tube formation (GO:0001841) | 2.69172805 |
| 158 | regulation of metalloenzyme activity (GO:0048552) | 2.67733560 |
| 159 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.66494706 |
| 160 | regulation of interleukin-8 secretion (GO:2000482) | 2.66190821 |
| 161 | keratan sulfate biosynthetic process (GO:0018146) | 2.62507453 |
| 162 | glycosphingolipid biosynthetic process (GO:0006688) | 2.60513926 |
| 163 | regulation of prostaglandin secretion (GO:0032306) | 2.58778902 |
| 164 | neurotransmitter biosynthetic process (GO:0042136) | 2.56181448 |
| 165 | developmental pigmentation (GO:0048066) | 2.54746437 |
| 166 | lateral ventricle development (GO:0021670) | 2.51134925 |
| 167 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.51085586 |
| 168 | positive regulation of actin filament depolymerization (GO:0030836) | 2.49873139 |
| 169 | positive regulation of interleukin-1 production (GO:0032732) | 2.49335725 |
| 170 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.48929630 |
| 171 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.47957344 |
| 172 | detection of external biotic stimulus (GO:0098581) | 2.47230043 |
| 173 | skeletal muscle adaptation (GO:0043501) | 2.45915327 |
| 174 | amino sugar metabolic process (GO:0006040) | 2.45267381 |
| 175 | positive regulation of epidermis development (GO:0045684) | 2.44837731 |
| 176 | * bicarbonate transport (GO:0015701) | 2.44595234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.94480298 |
| 2 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.28316697 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.23291527 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.90508952 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.75741726 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.64593344 |
| 7 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.64014146 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.59775506 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.50480667 |
| 10 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.47897880 |
| 11 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.36946671 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.31131166 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.29133746 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.23598097 |
| 15 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.22483059 |
| 16 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.19362807 |
| 17 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.14139940 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.08411388 |
| 19 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.08056004 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.07570820 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.05360577 |
| 22 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.04058685 |
| 23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.02249326 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.01731840 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.98444188 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.97362298 |
| 27 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.97088568 |
| 28 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.92554195 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80492121 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.80345034 |
| 31 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.78048020 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.77143741 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.76683803 |
| 34 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.71211524 |
| 35 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.68591817 |
| 36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68236933 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66343874 |
| 38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.66170695 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.65731672 |
| 40 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.64576595 |
| 41 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.62751960 |
| 42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56323615 |
| 43 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.56251570 |
| 44 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.56037522 |
| 45 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.55236337 |
| 46 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.52313256 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52094628 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.51930049 |
| 49 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.51808285 |
| 50 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.51730789 |
| 51 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51498934 |
| 52 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.50121187 |
| 53 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.49609488 |
| 54 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.48976024 |
| 55 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.48579827 |
| 56 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.48142228 |
| 57 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47720131 |
| 58 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.47712727 |
| 59 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.47256517 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45558554 |
| 61 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.44561482 |
| 62 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.43910138 |
| 63 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43441044 |
| 64 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.41918729 |
| 65 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.40839826 |
| 66 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.40325957 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39812730 |
| 68 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.39061198 |
| 69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.37981800 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37573851 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36538105 |
| 72 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.34963766 |
| 73 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.34289050 |
| 74 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.31463395 |
| 75 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.31441594 |
| 76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.31299498 |
| 77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31170177 |
| 78 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.29986649 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28903543 |
| 80 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.28578269 |
| 81 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28018593 |
| 82 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.26942257 |
| 83 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.26701705 |
| 84 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.25605432 |
| 85 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.25358431 |
| 86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24863120 |
| 87 | RXR_22108803_ChIP-Seq_LS180_Human | 1.24698269 |
| 88 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.23709192 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22962098 |
| 90 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.22897072 |
| 91 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.22073342 |
| 92 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22029518 |
| 93 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.21682170 |
| 94 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.21399471 |
| 95 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.19913619 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18979767 |
| 97 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.18186640 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18089409 |
| 99 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.17939872 |
| 100 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.17283398 |
| 101 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.16738721 |
| 102 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16671204 |
| 103 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.16574954 |
| 104 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.16570828 |
| 105 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 1.16400134 |
| 106 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.15825046 |
| 107 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15097373 |
| 108 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14577438 |
| 109 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13962575 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.13435436 |
| 111 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.12145047 |
| 112 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.11566548 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11099299 |
| 114 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.10498759 |
| 115 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.10498759 |
| 116 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.08874304 |
| 117 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.08853462 |
| 118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08724398 |
| 119 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.08651378 |
| 120 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08642850 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08173121 |
| 122 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07416784 |
| 123 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06922931 |
| 124 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06907917 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.06470537 |
| 126 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.06170034 |
| 127 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.05225873 |
| 128 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.04279022 |
| 129 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.03719125 |
| 130 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03464149 |
| 131 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03133863 |
| 132 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02940133 |
| 133 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01959092 |
| 134 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01904008 |
| 135 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01694351 |
| 136 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01565328 |
| 137 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01184479 |
| 138 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01053955 |
| 139 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.00785654 |
| 140 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99393043 |
| 141 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.99216146 |
| 142 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98863633 |
| 143 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.98615389 |
| 144 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.98248774 |
| 145 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.97633065 |
| 146 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97482739 |
| 147 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.93729230 |
| 148 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88318710 |
| 149 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.88034388 |
| 150 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86622102 |
| 151 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86169842 |
| 152 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85996425 |
| 153 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85773520 |
| 154 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85744874 |
| 155 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.85460215 |
| 156 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81745039 |
| 157 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.81182810 |
| 158 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.79149135 |
| 159 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78662625 |
| 160 | SA1_27219007_Chip-Seq_Bcells_Human | 0.77789659 |
| 161 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.76800650 |
| 162 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.74442219 |
| 163 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73868460 |
| 164 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.73366782 |
| 165 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.73274815 |
| 166 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.72986098 |
| 167 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.72658923 |
| 168 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.71902716 |
| 169 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.71790060 |
| 170 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71330547 |
| 171 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71171824 |
| 172 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71047320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.71058628 |
| 2 | MP0005377_hearing/vestibular/ear_phenot | 4.55315497 |
| 3 | MP0003878_abnormal_ear_physiology | 4.55315497 |
| 4 | MP0005360_urolithiasis | 4.41842326 |
| 5 | * MP0003866_abnormal_defecation | 3.62453232 |
| 6 | MP0005257_abnormal_intraocular_pressure | 3.44318377 |
| 7 | MP0005365_abnormal_bile_salt | 3.42698813 |
| 8 | MP0002277_abnormal_respiratory_mucosa | 3.32274260 |
| 9 | MP0000462_abnormal_digestive_system | 3.10264162 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 3.07369087 |
| 11 | MP0001873_stomach_inflammation | 2.94999673 |
| 12 | MP0000566_synostosis | 2.90933078 |
| 13 | MP0002822_catalepsy | 2.84941074 |
| 14 | MP0010155_abnormal_intestine_physiology | 2.78588989 |
| 15 | MP0001188_hyperpigmentation | 2.70555860 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.70042748 |
| 17 | * MP0001663_abnormal_digestive_system | 2.58779320 |
| 18 | MP0001664_abnormal_digestion | 2.55534352 |
| 19 | * MP0005381_digestive/alimentary_phenotyp | 2.47880546 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.41747558 |
| 21 | * MP0000490_abnormal_crypts_of | 2.41496408 |
| 22 | MP0002132_abnormal_respiratory_system | 2.18533647 |
| 23 | MP0005670_abnormal_white_adipose | 2.13859609 |
| 24 | MP0009379_abnormal_foot_pigmentation | 2.13246634 |
| 25 | MP0003283_abnormal_digestive_organ | 2.11785537 |
| 26 | MP0004264_abnormal_extraembryonic_tissu | 2.10827041 |
| 27 | MP0008004_abnormal_stomach_pH | 2.10775324 |
| 28 | MP0002009_preneoplasia | 2.09798866 |
| 29 | MP0006292_abnormal_olfactory_placode | 2.00720027 |
| 30 | MP0003879_abnormal_hair_cell | 1.83849381 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.83768622 |
| 32 | * MP0000477_abnormal_intestine_morphology | 1.81343182 |
| 33 | MP0003252_abnormal_bile_duct | 1.79648381 |
| 34 | MP0003136_yellow_coat_color | 1.79269424 |
| 35 | MP0005409_darkened_coat_color | 1.71761338 |
| 36 | MP0005310_abnormal_salivary_gland | 1.67497482 |
| 37 | MP0002163_abnormal_gland_morphology | 1.65244543 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.64474511 |
| 39 | MP0001986_abnormal_taste_sensitivity | 1.61959336 |
| 40 | MP0004381_abnormal_hair_follicle | 1.61714417 |
| 41 | MP0003315_abnormal_perineum_morphology | 1.61401804 |
| 42 | MP0004147_increased_porphyrin_level | 1.58023836 |
| 43 | MP0002796_impaired_skin_barrier | 1.56387515 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.49723660 |
| 45 | MP0004043_abnormal_pH_regulation | 1.47517327 |
| 46 | MP0000538_abnormal_urinary_bladder | 1.47368214 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.46442197 |
| 48 | MP0003941_abnormal_skin_development | 1.46276059 |
| 49 | MP0009840_abnormal_foam_cell | 1.46140518 |
| 50 | MP0000678_abnormal_parathyroid_gland | 1.42897167 |
| 51 | MP0000470_abnormal_stomach_morphology | 1.42751991 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.39818315 |
| 53 | * MP0001765_abnormal_ion_homeostasis | 1.38632730 |
| 54 | MP0003880_abnormal_central_pattern | 1.34276147 |
| 55 | MP0000613_abnormal_salivary_gland | 1.33042807 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.32344189 |
| 57 | MP0009785_altered_susceptibility_to | 1.29111082 |
| 58 | MP0000230_abnormal_systemic_arterial | 1.28201420 |
| 59 | MP0000537_abnormal_urethra_morphology | 1.27945608 |
| 60 | MP0002136_abnormal_kidney_physiology | 1.24343865 |
| 61 | MP0000015_abnormal_ear_pigmentation | 1.23654444 |
| 62 | MP0000372_irregular_coat_pigmentation | 1.16373391 |
| 63 | MP0010329_abnormal_lipoprotein_level | 1.15876140 |
| 64 | MP0002098_abnormal_vibrissa_morphology | 1.15274074 |
| 65 | MP0001764_abnormal_homeostasis | 1.09867948 |
| 66 | MP0005367_renal/urinary_system_phenotyp | 1.08183146 |
| 67 | MP0000516_abnormal_urinary_system | 1.08183146 |
| 68 | MP0009697_abnormal_copulation | 1.07272084 |
| 69 | MP0001346_abnormal_lacrimal_gland | 1.05690834 |
| 70 | MP0005501_abnormal_skin_physiology | 1.05407070 |
| 71 | MP0005332_abnormal_amino_acid | 1.04701025 |
| 72 | MP0001756_abnormal_urination | 1.04238431 |
| 73 | MP0003303_peritoneal_inflammation | 1.04049643 |
| 74 | MP0005166_decreased_susceptibility_to | 1.03377466 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 0.98048355 |
| 76 | MP0005025_abnormal_response_to | 0.97218477 |
| 77 | MP0003724_increased_susceptibility_to | 0.97016404 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 0.96251126 |
| 79 | MP0002118_abnormal_lipid_homeostasis | 0.96232077 |
| 80 | MP0005171_absent_coat_pigmentation | 0.92639059 |
| 81 | MP0002006_tumorigenesis | 0.92518423 |
| 82 | MP0000609_abnormal_liver_physiology | 0.92492341 |
| 83 | MP0005379_endocrine/exocrine_gland_phen | 0.92120663 |
| 84 | MP0005671_abnormal_response_to | 0.92107435 |
| 85 | MP0004742_abnormal_vestibular_system | 0.91948115 |
| 86 | MP0010386_abnormal_urinary_bladder | 0.89200157 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.88818324 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.88550648 |
| 89 | MP0003938_abnormal_ear_development | 0.85176408 |
| 90 | MP0002095_abnormal_skin_pigmentation | 0.84122896 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.83322965 |
| 92 | MP0004484_altered_response_of | 0.82796222 |
| 93 | MP0005165_increased_susceptibility_to | 0.81800456 |
| 94 | MP0002971_abnormal_brown_adipose | 0.81700167 |
| 95 | MP0010678_abnormal_skin_adnexa | 0.80921397 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.80092293 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.79202395 |
| 98 | MP0001800_abnormal_humoral_immune | 0.78441512 |
| 99 | MP0003300_gastrointestinal_ulcer | 0.78298618 |
| 100 | MP0002452_abnormal_antigen_presenting | 0.78035384 |
| 101 | * MP0005636_abnormal_mineral_homeostasis | 0.77424320 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.76878737 |
| 103 | MP0008872_abnormal_physiological_respon | 0.76682446 |
| 104 | MP0001819_abnormal_immune_cell | 0.76510167 |
| 105 | MP0006082_CNS_inflammation | 0.75281268 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.75219042 |
| 107 | MP0006276_abnormal_autonomic_nervous | 0.74604788 |
| 108 | MP0001485_abnormal_pinna_reflex | 0.74467784 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.73421526 |
| 110 | MP0005085_abnormal_gallbladder_physiolo | 0.72776428 |
| 111 | MP0001440_abnormal_grooming_behavior | 0.72727492 |
| 112 | MP0000383_abnormal_hair_follicle | 0.71993482 |
| 113 | MP0009764_decreased_sensitivity_to | 0.71715061 |
| 114 | MP0001963_abnormal_hearing_physiology | 0.71651098 |
| 115 | MP0001845_abnormal_inflammatory_respons | 0.71607498 |
| 116 | MP0000049_abnormal_middle_ear | 0.71396972 |
| 117 | MP0002420_abnormal_adaptive_immunity | 0.71245173 |
| 118 | MP0003705_abnormal_hypodermis_morpholog | 0.70440951 |
| 119 | MP0004019_abnormal_vitamin_homeostasis | 0.69749446 |
| 120 | MP0003693_abnormal_embryo_hatching | 0.69502173 |
| 121 | MP0009115_abnormal_fat_cell | 0.69364618 |
| 122 | MP0001501_abnormal_sleep_pattern | 0.69309138 |
| 123 | MP0001790_abnormal_immune_system | 0.68825582 |
| 124 | MP0005387_immune_system_phenotype | 0.68825582 |
| 125 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68695514 |
| 126 | MP0001849_ear_inflammation | 0.68545526 |
| 127 | MP0000467_abnormal_esophagus_morphology | 0.68472435 |
| 128 | MP0003385_abnormal_body_wall | 0.68436430 |
| 129 | MP0005451_abnormal_body_composition | 0.68203725 |
| 130 | MP0000026_abnormal_inner_ear | 0.66975382 |
| 131 | MP0002166_altered_tumor_susceptibility | 0.66356638 |
| 132 | MP0000762_abnormal_tongue_morphology | 0.65802059 |
| 133 | MP0008875_abnormal_xenobiotic_pharmacok | 0.65566248 |
| 134 | MP0004947_skin_inflammation | 0.62273837 |
| 135 | MP0001216_abnormal_epidermal_layer | 0.62038841 |
| 136 | MP0003191_abnormal_cellular_cholesterol | 0.61793734 |
| 137 | MP0003806_abnormal_nucleotide_metabolis | 0.60952689 |
| 138 | MP0005448_abnormal_energy_balance | 0.59274612 |
| 139 | MP0009780_abnormal_chondrocyte_physiolo | 0.57657430 |
| 140 | MP0004858_abnormal_nervous_system | 0.57040804 |
| 141 | MP0009333_abnormal_splenocyte_physiolog | 0.53858462 |
| 142 | * MP0009642_abnormal_blood_homeostasis | 0.53058849 |
| 143 | MP0005058_abnormal_lysosome_morphology | 0.52520347 |
| 144 | MP0000377_abnormal_hair_follicle | 0.51465337 |
| 145 | MP0003567_abnormal_fetal_cardiomyocyte | 0.45673763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Decreased circulating renin level (HP:0003351) | 5.87361418 |
| 2 | * Hyperactive renin-angiotensin system (HP:0000841) | 5.30713495 |
| 3 | Ileus (HP:0002595) | 5.13444298 |
| 4 | Prostate neoplasm (HP:0100787) | 4.70185048 |
| 5 | Chronic diarrhea (HP:0002028) | 4.26817854 |
| 6 | Congenital sensorineural hearing impairment (HP:0008527) | 4.21587151 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.19141400 |
| 8 | Cheilitis (HP:0100825) | 4.14995410 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 3.86235748 |
| 10 | Right ventricular cardiomyopathy (HP:0011663) | 3.70612723 |
| 11 | Amelogenesis imperfecta (HP:0000705) | 3.67480236 |
| 12 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.66164099 |
| 13 | Abnormality of dental color (HP:0011073) | 3.65736378 |
| 14 | Fat malabsorption (HP:0002630) | 3.55068727 |
| 15 | Alopecia of scalp (HP:0002293) | 3.45166778 |
| 16 | * Alkalosis (HP:0001948) | 3.43590654 |
| 17 | Flat capital femoral epiphysis (HP:0003370) | 3.41225293 |
| 18 | Visceral angiomatosis (HP:0100761) | 3.39859959 |
| 19 | Abnormality of vitamin B metabolism (HP:0004340) | 3.39404986 |
| 20 | Hyperkalemia (HP:0002153) | 3.35515633 |
| 21 | Hemorrhage of the eye (HP:0011885) | 3.26361873 |
| 22 | Parakeratosis (HP:0001036) | 3.26241131 |
| 23 | Flat acetabular roof (HP:0003180) | 3.16404472 |
| 24 | Abnormal biliary tract morphology (HP:0012440) | 3.16283775 |
| 25 | Conjugated hyperbilirubinemia (HP:0002908) | 3.13616429 |
| 26 | Cone-rod dystrophy (HP:0000548) | 3.11630344 |
| 27 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.09204399 |
| 28 | Hemangiomatosis (HP:0007461) | 3.05992005 |
| 29 | Abnormality of carpal bone ossification (HP:0006257) | 2.98041012 |
| 30 | Petechiae (HP:0000967) | 2.97680763 |
| 31 | Malnutrition (HP:0004395) | 2.96790365 |
| 32 | Reduced antithrombin III activity (HP:0001976) | 2.92929523 |
| 33 | Vertebral hypoplasia (HP:0008417) | 2.92256434 |
| 34 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.92256434 |
| 35 | * Abnormality of renin-angiotensin system (HP:0000847) | 2.88194150 |
| 36 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.86532325 |
| 37 | Abnormal cartilage morphology (HP:0002763) | 2.83784057 |
| 38 | Abnormality of vitamin metabolism (HP:0100508) | 2.83289020 |
| 39 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.82063233 |
| 40 | Abnormal tarsal ossification (HP:0008369) | 2.80790222 |
| 41 | Thin bony cortex (HP:0002753) | 2.78625023 |
| 42 | Vertebral clefting (HP:0008428) | 2.77998722 |
| 43 | Abnormal vertebral ossification (HP:0100569) | 2.76698069 |
| 44 | Unilateral renal agenesis (HP:0000122) | 2.72160608 |
| 45 | Large earlobe (HP:0009748) | 2.71561476 |
| 46 | Abnormal ciliary motility (HP:0012262) | 2.71096860 |
| 47 | Renal tubular acidosis (HP:0001947) | 2.69586148 |
| 48 | Abnormality of the 1st metacarpal (HP:0010009) | 2.64664897 |
| 49 | Flattened epiphyses (HP:0003071) | 2.64461392 |
| 50 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.63246482 |
| 51 | Irregular epiphyses (HP:0010582) | 2.62547595 |
| 52 | Absent/shortened dynein arms (HP:0200106) | 2.61168219 |
| 53 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.61168219 |
| 54 | Ureteral stenosis (HP:0000071) | 2.57865531 |
| 55 | Pustule (HP:0200039) | 2.54035463 |
| 56 | Nonprogressive disorder (HP:0003680) | 2.51012649 |
| 57 | Abnormality of the prostate (HP:0008775) | 2.49239068 |
| 58 | Ureteral obstruction (HP:0006000) | 2.48806024 |
| 59 | Hyperphosphatemia (HP:0002905) | 2.47133133 |
| 60 | Confusion (HP:0001289) | 2.46887604 |
| 61 | Aplasia cutis congenita (HP:0001057) | 2.46558688 |
| 62 | * Abnormality of potassium homeostasis (HP:0011042) | 2.41827854 |
| 63 | Palpitations (HP:0001962) | 2.41725015 |
| 64 | * Abdominal distention (HP:0003270) | 2.41434024 |
| 65 | Hyperammonemia (HP:0001987) | 2.40357309 |
| 66 | * Hyperaldosteronism (HP:0000859) | 2.36701178 |
| 67 | Acanthocytosis (HP:0001927) | 2.36646979 |
| 68 | Neonatal short-limb short stature (HP:0008921) | 2.36409564 |
| 69 | Gastrointestinal dysmotility (HP:0002579) | 2.36333185 |
| 70 | Biliary tract neoplasm (HP:0100574) | 2.33110991 |
| 71 | Vacuolated lymphocytes (HP:0001922) | 2.32329539 |
| 72 | Eczematoid dermatitis (HP:0000976) | 2.31571159 |
| 73 | Hypotension (HP:0002615) | 2.30569435 |
| 74 | Breech presentation (HP:0001623) | 2.30075940 |
| 75 | Patchy hypopigmentation of hair (HP:0011365) | 2.29996093 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27098650 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.27098650 |
| 78 | Focal segmental glomerulosclerosis (HP:0000097) | 2.25942340 |
| 79 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.23964372 |
| 80 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.23809376 |
| 81 | * Metabolic alkalosis (HP:0200114) | 2.21721590 |
| 82 | Abnormal hair laboratory examination (HP:0003328) | 2.18362099 |
| 83 | Hydroxyprolinuria (HP:0003080) | 2.16169198 |
| 84 | Abnormality of proline metabolism (HP:0010907) | 2.16169198 |
| 85 | Hoarse voice (HP:0001609) | 2.15829502 |
| 86 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.14038508 |
| 87 | Cupped ribs (HP:0000887) | 2.13703283 |
| 88 | Short middle phalanx of finger (HP:0005819) | 2.12362310 |
| 89 | Protuberant abdomen (HP:0001538) | 2.12089964 |
| 90 | Villous atrophy (HP:0011473) | 2.11813122 |
| 91 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.11813122 |
| 92 | Autoimmune hemolytic anemia (HP:0001890) | 2.11173753 |
| 93 | Progressive sensorineural hearing impairment (HP:0000408) | 2.09794995 |
| 94 | Type I transferrin isoform profile (HP:0003642) | 2.07454247 |
| 95 | Abnormal hand bone ossification (HP:0010660) | 2.05665045 |
| 96 | * Hypokalemia (HP:0002900) | 2.04301267 |
| 97 | * Hyponatremia (HP:0002902) | 2.01462155 |
| 98 | Severe short stature (HP:0003510) | 2.00934925 |
| 99 | Systemic lupus erythematosus (HP:0002725) | 1.99874581 |
| 100 | Septate vagina (HP:0001153) | 1.99404071 |
| 101 | Enlarged epiphyses (HP:0010580) | 1.99403336 |
| 102 | Abnormality of the 2nd finger (HP:0004100) | 1.99394203 |
| 103 | Wide cranial sutures (HP:0010537) | 1.99255754 |
| 104 | Short tibia (HP:0005736) | 1.98893332 |
| 105 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.97023128 |
| 106 | Follicular hyperkeratosis (HP:0007502) | 1.96569039 |
| 107 | Widely patent fontanelles and sutures (HP:0004492) | 1.95519586 |
| 108 | Hypobetalipoproteinemia (HP:0003563) | 1.95152494 |
| 109 | Curly hair (HP:0002212) | 1.94738303 |
| 110 | * Dehydration (HP:0001944) | 1.94735752 |
| 111 | Neoplasm of the rectum (HP:0100743) | 1.93751209 |
| 112 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.93336278 |
| 113 | Rectal prolapse (HP:0002035) | 1.92139869 |
| 114 | * Abnormality of chloride homeostasis (HP:0011422) | 1.92117435 |
| 115 | Abnormality of magnesium homeostasis (HP:0004921) | 1.91018886 |
| 116 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.90999077 |
| 117 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.90999077 |
| 118 | Abnormal ossification of hand bones (HP:0005921) | 1.90782740 |
| 119 | Ectropion (HP:0000656) | 1.90731161 |
| 120 | Absent eyebrow (HP:0002223) | 1.90641986 |
| 121 | Spinal cord compression (HP:0002176) | 1.90491708 |
| 122 | Alveolar cell carcinoma (HP:0006519) | 1.88675608 |
| 123 | Syncope (HP:0001279) | 1.88514847 |
| 124 | Plantar hyperkeratosis (HP:0007556) | 1.86889740 |
| 125 | Hip contracture (HP:0003273) | 1.85108921 |
| 126 | White forelock (HP:0002211) | 1.85067143 |
| 127 | Delayed epiphyseal ossification (HP:0002663) | 1.83744423 |
| 128 | Bone pain (HP:0002653) | 1.82479326 |
| 129 | Tetany (HP:0001281) | 1.82167186 |
| 130 | Abnormality of the costochondral junction (HP:0000919) | 1.80867839 |
| 131 | Bradycardia (HP:0001662) | 1.80297711 |
| 132 | Cerebral palsy (HP:0100021) | 1.80067016 |
| 133 | Conical tooth (HP:0000698) | 1.79969535 |
| 134 | Short phalanx of the thumb (HP:0009660) | 1.76793004 |
| 135 | Pigmentary retinal degeneration (HP:0001146) | 1.75999171 |
| 136 | Increased circulating renin level (HP:0000848) | 1.75386933 |
| 137 | Glomerulosclerosis (HP:0000096) | 1.74522074 |
| 138 | Woolly hair (HP:0002224) | 1.74295610 |
| 139 | Recurrent pneumonia (HP:0006532) | 1.74225034 |
| 140 | Pili torti (HP:0003777) | 1.74106063 |
| 141 | Metabolic acidosis (HP:0001942) | 1.73742621 |
| 142 | Abnormal foot bone ossification (HP:0010675) | 1.73146373 |
| 143 | Late onset (HP:0003584) | 1.72984285 |
| 144 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.71834016 |
| 145 | Blepharitis (HP:0000498) | 1.71730630 |
| 146 | Premature loss of primary teeth (HP:0006323) | 1.70997860 |
| 147 | Hyperparathyroidism (HP:0000843) | 1.70747989 |
| 148 | Decreased central vision (HP:0007663) | 1.69998450 |
| 149 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.68687410 |
| 150 | Osteomalacia (HP:0002749) | 1.68300073 |
| 151 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.67733238 |
| 152 | Recurrent cutaneous fungal infections (HP:0011370) | 1.67707236 |
| 153 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.67707236 |
| 154 | Fragile nails (HP:0001808) | 1.66827117 |
| 155 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.66102651 |
| 156 | Onycholysis (HP:0001806) | 1.64507743 |
| 157 | Symptomatic seizures (HP:0011145) | 1.62549035 |
| 158 | Anhidrosis (HP:0000970) | 1.61742552 |
| 159 | Progressive hearing impairment (HP:0001730) | 1.61563111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 6.74529243 |
| 2 | MST1R | 4.62571758 |
| 3 | RIPK1 | 4.21112239 |
| 4 | MST4 | 3.67213382 |
| 5 | PIK3CA | 3.55657697 |
| 6 | CASK | 3.37130937 |
| 7 | FRK | 3.08837594 |
| 8 | LMTK2 | 2.91661904 |
| 9 | SIK3 | 2.89241479 |
| 10 | TNIK | 2.78109355 |
| 11 | MYLK | 2.67685768 |
| 12 | STK39 | 2.63187158 |
| 13 | MAP3K10 | 2.51478257 |
| 14 | PRKD2 | 2.43914417 |
| 15 | ERN1 | 2.41256803 |
| 16 | TAOK3 | 2.19111024 |
| 17 | PRKG2 | 2.17517711 |
| 18 | IRAK3 | 2.14901600 |
| 19 | MAP2K2 | 2.11250566 |
| 20 | TXK | 2.07348325 |
| 21 | STK38 | 1.92242918 |
| 22 | EPHB2 | 1.86863659 |
| 23 | OXSR1 | 1.76423496 |
| 24 | YES1 | 1.72049046 |
| 25 | PTK6 | 1.68357937 |
| 26 | MAP3K14 | 1.63283046 |
| 27 | MAPK15 | 1.48991028 |
| 28 | NME1 | 1.48109397 |
| 29 | RIPK4 | 1.46713225 |
| 30 | PDK2 | 1.46125881 |
| 31 | IRAK4 | 1.43002942 |
| 32 | GRK6 | 1.40884464 |
| 33 | NLK | 1.36838142 |
| 34 | WNK4 | 1.33214186 |
| 35 | MUSK | 1.29646234 |
| 36 | TEC | 1.28771224 |
| 37 | DMPK | 1.27613222 |
| 38 | CDK8 | 1.20265290 |
| 39 | NUAK1 | 1.18982520 |
| 40 | AKT3 | 1.17934893 |
| 41 | MAP3K12 | 1.17515387 |
| 42 | CLK1 | 1.15777148 |
| 43 | INSRR | 1.15555626 |
| 44 | MKNK2 | 1.13739891 |
| 45 | PIK3CG | 1.08950097 |
| 46 | IKBKE | 1.06599041 |
| 47 | GRK7 | 1.06114031 |
| 48 | SIK2 | 1.02456115 |
| 49 | GRK1 | 0.97890120 |
| 50 | EIF2AK2 | 0.95303909 |
| 51 | DDR2 | 0.93729739 |
| 52 | PRKAA2 | 0.93611471 |
| 53 | PDPK1 | 0.89659925 |
| 54 | FGFR4 | 0.87997791 |
| 55 | STK38L | 0.86595280 |
| 56 | ADRBK2 | 0.85311914 |
| 57 | MAPK11 | 0.83152858 |
| 58 | CDK3 | 0.81829857 |
| 59 | EPHA3 | 0.81652205 |
| 60 | BMPR1B | 0.80624398 |
| 61 | TLK1 | 0.78560177 |
| 62 | ZAK | 0.76293235 |
| 63 | ABL2 | 0.75893879 |
| 64 | TBK1 | 0.74789941 |
| 65 | EPHB1 | 0.74372323 |
| 66 | MET | 0.73807923 |
| 67 | MARK3 | 0.73756588 |
| 68 | MAP3K2 | 0.71166197 |
| 69 | TAOK1 | 0.70304658 |
| 70 | MATK | 0.68658515 |
| 71 | STK11 | 0.68186683 |
| 72 | TYK2 | 0.67782432 |
| 73 | BLK | 0.65727786 |
| 74 | MAP3K1 | 0.65179597 |
| 75 | SIK1 | 0.64296949 |
| 76 | FGFR3 | 0.64253104 |
| 77 | BMPR2 | 0.63334396 |
| 78 | PDK1 | 0.63064539 |
| 79 | MAP3K13 | 0.62827969 |
| 80 | TESK1 | 0.62696281 |
| 81 | EPHA4 | 0.58248073 |
| 82 | PAK4 | 0.57154379 |
| 83 | FGR | 0.57152212 |
| 84 | MAPK13 | 0.56474544 |
| 85 | MAPKAPK5 | 0.56232870 |
| 86 | ITK | 0.55999651 |
| 87 | CSK | 0.55986246 |
| 88 | SGK2 | 0.54788300 |
| 89 | MAP2K7 | 0.53138848 |
| 90 | IKBKB | 0.52912632 |
| 91 | CDK9 | 0.52527009 |
| 92 | FER | 0.52522142 |
| 93 | MAP2K1 | 0.52325214 |
| 94 | PTK2 | 0.51845568 |
| 95 | TNK2 | 0.51775095 |
| 96 | CAMK2D | 0.50837623 |
| 97 | MAPKAPK3 | 0.49850882 |
| 98 | EPHA2 | 0.49176351 |
| 99 | CDC42BPA | 0.46719844 |
| 100 | PRKACG | 0.46096324 |
| 101 | STK10 | 0.45781375 |
| 102 | KSR2 | 0.45751285 |
| 103 | PRKCI | 0.44943281 |
| 104 | PIM2 | 0.44603188 |
| 105 | PRKAA1 | 0.43103859 |
| 106 | MAP2K6 | 0.43037598 |
| 107 | LYN | 0.42952351 |
| 108 | MAP3K7 | 0.41564839 |
| 109 | ERBB2 | 0.40998398 |
| 110 | PIM1 | 0.40585838 |
| 111 | TGFBR2 | 0.39466012 |
| 112 | TESK2 | 0.39461785 |
| 113 | SRC | 0.38870736 |
| 114 | MAP4K1 | 0.38177898 |
| 115 | CAMK2B | 0.36607321 |
| 116 | RET | 0.36488480 |
| 117 | PRKG1 | 0.36026553 |
| 118 | MAPKAPK2 | 0.35810205 |
| 119 | SRPK1 | 0.35279713 |
| 120 | PRKCA | 0.34773649 |
| 121 | CAMK1 | 0.33492667 |
| 122 | IRAK1 | 0.32250138 |
| 123 | TSSK6 | 0.31639587 |
| 124 | PRPF4B | 0.31617171 |
| 125 | MKNK1 | 0.30011277 |
| 126 | SGK3 | 0.28498895 |
| 127 | CAMK2G | 0.27983588 |
| 128 | CSNK1A1 | 0.26723588 |
| 129 | VRK1 | 0.26669623 |
| 130 | STK24 | 0.25340478 |
| 131 | IRAK2 | 0.25119087 |
| 132 | FYN | 0.24849562 |
| 133 | RPS6KA2 | 0.24616178 |
| 134 | DYRK1B | 0.23739896 |
| 135 | NEK6 | 0.22840180 |
| 136 | JAK2 | 0.21312740 |
| 137 | SMG1 | 0.20444281 |
| 138 | PDGFRA | 0.18865938 |
| 139 | PRKCD | 0.18641328 |
| 140 | TRIB3 | 0.17685360 |
| 141 | CDK19 | 0.16241804 |
| 142 | PRKCZ | 0.15665131 |
| 143 | PRKCB | 0.14898886 |
| 144 | EEF2K | 0.14187040 |
| 145 | PRKCQ | 0.13258709 |
| 146 | BCR | 0.13092559 |
| 147 | BMX | 0.12783907 |
| 148 | IGF1R | 0.12437144 |
| 149 | WNK1 | 0.12070406 |
| 150 | MAP3K11 | 0.11533999 |
| 151 | ZAP70 | 0.10195342 |
| 152 | ROCK1 | 0.09948571 |
| 153 | CDK6 | 0.08809379 |
| 154 | MAP3K8 | 0.08310636 |
| 155 | RPS6KB1 | 0.07111689 |
| 156 | MAPK7 | 0.07031484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 5.03884106 |
| 2 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 4.48189208 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.30165664 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.05237059 |
| 5 | * Mineral absorption_Homo sapiens_hsa04978 | 3.84746074 |
| 6 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 3.57329925 |
| 7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.17300845 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.81466443 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.52104283 |
| 10 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.29758546 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.21371455 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.14701693 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.06693111 |
| 14 | Retinol metabolism_Homo sapiens_hsa00830 | 1.91564218 |
| 15 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.74407867 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.73421537 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71478018 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.70063516 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.68790800 |
| 20 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.57328220 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.53418422 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.51411212 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.38180509 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.33667975 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.27105627 |
| 26 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.22096920 |
| 27 | Thyroid cancer_Homo sapiens_hsa05216 | 1.21912778 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21670977 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.20483265 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16733832 |
| 31 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.16315279 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14989244 |
| 33 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.14557110 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.13525897 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11690634 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11582130 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11286949 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10015153 |
| 39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.05362896 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05048714 |
| 41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.04488373 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.03866987 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03407387 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02235585 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.02140969 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.02010066 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01647997 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00899647 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98688881 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.94825342 |
| 51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92404254 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88734854 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 0.88596976 |
| 54 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.86694748 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.85380641 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.84868873 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.82012386 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.81813344 |
| 59 | Measles_Homo sapiens_hsa05162 | 0.81059024 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79877005 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78932788 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76918496 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.76894574 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76462718 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75032202 |
| 66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74412417 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72963323 |
| 68 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.72643931 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72070667 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71492521 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69513705 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66143245 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64845868 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.64663921 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64065931 |
| 76 | Taste transduction_Homo sapiens_hsa04742 | 0.62764042 |
| 77 | Tight junction_Homo sapiens_hsa04530 | 0.61098963 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61064700 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.57794827 |
| 80 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55334785 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53940631 |
| 82 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.53833335 |
| 83 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53769470 |
| 84 | Leishmaniasis_Homo sapiens_hsa05140 | 0.53198716 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.52944155 |
| 86 | Nicotine addiction_Homo sapiens_hsa05033 | 0.51601427 |
| 87 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50538927 |
| 88 | Homologous recombination_Homo sapiens_hsa03440 | 0.50118249 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49340056 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48517003 |
| 91 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46639791 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46584027 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46054469 |
| 94 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.45952929 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.45929271 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45832858 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.45624754 |
| 98 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.44020579 |
| 99 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.42093727 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41684764 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41417370 |
| 102 | Renin secretion_Homo sapiens_hsa04924 | 0.41261534 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41036955 |
| 104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40212402 |
| 105 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39950184 |
| 106 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.38110968 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36284752 |
| 108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35186906 |
| 109 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.34990074 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.34208508 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34199480 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32909071 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.32427839 |
| 114 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.32411208 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32242424 |
| 116 | Prostate cancer_Homo sapiens_hsa05215 | 0.31859247 |
| 117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31654525 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.31491566 |
| 119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31260479 |
| 120 | Carbon metabolism_Homo sapiens_hsa01200 | 0.29842308 |
| 121 | Asthma_Homo sapiens_hsa05310 | 0.28859686 |
| 122 | Allograft rejection_Homo sapiens_hsa05330 | 0.28533424 |
| 123 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.28340756 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.28334473 |
| 125 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.28254017 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.26328456 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.24007705 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18277498 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18267256 |
| 130 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.17289544 |
| 131 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.13766858 |
| 132 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.10096212 |
| 133 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.08519972 |
| 134 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.06423471 |
| 135 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.05875937 |
| 136 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.04595724 |
| 137 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.02810275 |
| 138 | Insulin secretion_Homo sapiens_hsa04911 | 0.01498534 |
| 139 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0339283 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0299145 |
| 141 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | -0.0054768 |

